Brian F. McLaughlin's most recent trade in Lifecore Biomedical Inc was a trade of 5,000 Common Stock done at an average price of $10.1 . Disclosure was reported to the exchange on Oct. 19, 2020.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lifecore Biomedical Inc | Brian F. McLaughlin | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.09 per share. | 19 Oct 2020 | 5,000 | 19,532 (0%) | 0% | 10.1 | 50,450 | Common Stock |
| Lifecore Biomedical Inc | Brian F. McLaughlin | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Oct 2020 | 5,000 | 0 | - | - | Restricted Stock Unit | |
| Lifecore Biomedical Inc | Brian F. McLaughlin | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.09 per share. | 19 Oct 2020 | 2,479 | 17,053 (0%) | 0% | 10.1 | 25,013 | Common Stock |